LONG-TERM SIDE EFFECTS OF TREATMENT FOR TESTIS CANCER

Aass, 1990, Renal function related to different treatment modalities for malignant germ cell tumours, Br J Cancer, 62, 842, 10.1038/bjc.1990.391 Bajorin, 1993, Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy, J Natl Cancer Inst, 85, 60, 10.1093/jnci/85.1.60 Baniel, 1995, Late relapse of clinical stage I testicular cancer, J Urol, 154, 1370, 10.1016/S0022-5347(01)66867-8 Baniel, 1995, Late relapse of testicular cancer, J Clin Oncol, 13, 1170, 10.1200/JCO.1995.13.5.1170 Baniel, 1995, Complications of post-chemotherapy retroperitoneal lymph node dissection, J Urol, 153, 976, 10.1016/S0022-5347(01)67616-X Berthelsen, 1984, Sperm counts and serum follicle-stimulating hormone levels before and after radiotherapy and chemotherapy in men with testicular germ cell cancer, Fertil Steril, 41, 281, 10.1016/S0015-0282(16)47605-3 Bokemeyer, 1993, Secondary neoplasms following treatment of malignant germ cell tumors, J Clin Oncol, 11, 1703, 10.1200/JCO.1993.11.9.1703 Borge, 1988, Late recurrence of testicular cancer, J Clin Oncol, 6, 1248, 10.1200/JCO.1988.6.8.1248 Boyer, 1992, Toxicity of treatment of germ cell tumors, Semin Oncol, 19, 128 Brennemann, 1997, Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer, J Urol, 158, 844, 10.1016/S0022-5347(01)64333-7 Carroll, 1987, Endocrine and exocrine profiles of men with testicular tumors before orchiectomy, J Urol, 137, 420, 10.1016/S0022-5347(17)44054-7 Chao, 1995, Secondary malignancy among seminoma patients treated with adjuvant radiation therapy, Int J Radiat Oncol Biol Phys, 33, 831, 10.1016/0360-3016(95)00200-8 Chong, 1986, Orchiectomy in advanced germ cell cancer following intensive chemotherapy: A comparison of systemic to testicular response, J Urol, 136, 1221, 10.1016/S0022-5347(17)45290-6 Coogan, 1996, Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer, J Urol, 156, 1656, 10.1016/S0022-5347(01)65476-4 Cullen, 1996, Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: A Medical Research Council report, J Clin Oncol, 14, 1106, 10.1200/JCO.1996.14.4.1106 Dearnaley, 1991, Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: Long-term follow-up, Eur J Cancer, 27, 684, 10.1016/0277-5379(91)90166-B DeLeo, 1988, Late recurrences in long-term survivors of germ cell neoplasms, Cancer, 62, 985, 10.1002/1097-0142(19880901)62:5<985::AID-CNCR2820620524>3.0.CO;2-8 Dieckmann, 1996, Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms, J Clin Oncol, 14, 3126, 10.1200/JCO.1996.14.12.3126 Donohue, 1990, Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation, J Urol, 144, 287, 10.1016/S0022-5347(17)39434-X Donohue, 1981, Complications of retroperitoneal lymph node dissection, J Urol, 125, 338, 10.1016/S0022-5347(17)55029-6 Donohue, 1995, Clinical stage B non-seminomatous germ cell testis cancer: The Indiana University experience (1965–1989) using routine primary retroperitoneal lymph node dissection, Eur J Cancer, 31A, 1599, 10.1016/0959-8049(95)00330-L Donohue, 1995, The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: The Indiana University experience (1965 to 1989), J Urol, 153, 85, 10.1097/00005392-199501000-00030 Drasga, 1983, Fertility after chemotherapy for testicular cancer, J Clin Oncol, 1, 179, 10.1200/JCO.1983.1.3.179 Einhorn, 1981, Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture, Cancer Res, 41, 3275 Ellis, 1992, Fasting plasma lipid measurements following cisplatin chemotherapy in patients with germ cell tumors, J Clin Oncol, 10, 1609, 10.1200/JCO.1992.10.10.1609 Fossa, 1989, Radiotherapy for testicular seminoma stage I: Treatment results and long-term post-irradiation morbidity in 365 patients, Int J Radiat Oncol Biol Phys, 16, 383, 10.1016/0360-3016(89)90334-9 Fossa, 1990, Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy, Br J Cancer, 61, 639, 10.1038/bjc.1990.142 Foster, 1994, The fertility of patients with clinical stage I testis cancer managed by nerve sparing retroperitoneal lymph node dissection, J Urol, 152, 1139, 10.1016/S0022-5347(17)32523-5 Ginsberg, 1982, The pulmonary toxicity of antineoplastic agents, Semin Oncol, 9, 34 Gordon, 1997, A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Southwest Oncology Group, Int J Radiat Oncol Biol Phys, 38, 83, 10.1016/S0360-3016(97)00235-6 Hanks, 1992, Seminoma of the testis: Long-term beneficial and deleterious results of radiation, Int J Radiat Oncol Biol Phys, 24, 913, 10.1016/0360-3016(92)90475-W Hansen, 1990, Long-term recovery of spermatogenesis after radiotherapy in patients with testicular cancer, Radiother Oncol, 18, 117, 10.1016/0167-8140(90)90137-L Hansen, 1990, Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance, J Clin Oncol, 8, 1695, 10.1200/JCO.1990.8.10.1695 Hay, 1984, Subsequent malignancies in patients irradiated for testicular tumours, Br J Radiol, 57, 597, 10.1259/0007-1285-57-679-597 Henderson, 1988, Epidemiology of testicular cancer, 46 Horwich, 1994, Mortality and cancer incidence following radiotherapy for seminoma of the testis, Radiother Oncol, 30, 193, 10.1016/0167-8140(94)90457-X Jacobsen, 1993, Increased incidence of sarcoma in patients treated for testicular seminoma, Eur J Cancer, 29A, 664, 10.1016/S0959-8049(05)80342-9 Jacobsen, 1997, External beam abdominal radiotherapy in patients with seminoma stage I: Field type, testicular dose, and spermatogenesis, Int J Radiat Oncol Biol Phys, 38, 95, 10.1016/S0360-3016(96)00597-4 Joos, 1997, Endocrine profiles after radiotherapy in stage I seminoma: Impact of two different radiation treatment modalities, Radiother Oncol, 43, 159, 10.1016/S0167-8140(97)00052-2 Kaldor, 1987, Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: An international collaborative study among cancer registries, Int J Cancer, 39, 571, 10.1002/ijc.2910390506 Landis, 1998, Cancer statistics, 1998, CA Cancer J Clin, 48, 6, 10.3322/canjclin.48.1.6 Lange, 1987, Fertility issues in the therapy of nonseminomatous testicular tumors, Urol Clin North Am, 14, 731, 10.1016/S0094-0143(21)01555-X Malas, 1996, Toxicity in patients with testicular seminoma treated with radiotherapy. Different dose levels and treatment fields, Acta Oncol, 35, 201, 10.3109/02841869609098502 McKeage, 1990, Carbon monoxide diffusing capacity is a poor predictor of clinically significant bleomycin lung. New Zealand Clinical Oncology Group, J Clin Oncol, 8, 779, 10.1200/JCO.1990.8.5.779 Molassiotis, 1995, Gonadal function and psychosexual adjustment in male long-term survivors of bone marrow transplantation, Bone Marrow Transplant, 16, 253 Nichols, 1993, Secondary leukemia associated with a conventional dose of etoposide: Review of serial germ cell tumor protocols, J Natl Cancer Inst, 85, 36, 10.1093/jnci/85.1.36 Nichols, 1992, No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: An analysis of the Testicular Cancer Intergroup Study, J Clin Oncol, 10, 760, 10.1200/JCO.1992.10.5.760 Nijman, 1987, Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumors, J Clin Oncol, 5, 651, 10.1200/JCO.1987.5.4.651 Palmieri, 1996, Gonadal function after multimodality treatment in men with testicular germ cell cancer, Eur J Endocrinol, 134, 431, 10.1530/eje.0.1340431 Parker, 1997, Cancer statistics, 1997, CA Cancer J Clin, 47, 5, 10.3322/canjclin.47.1.5 Pedersen-Bjergaard, 1991, Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours, Lancet, 338, 359, 10.1016/0140-6736(91)90490-G Presti, 1993, Fertility and testis cancer, Urol Clin North Am, 20, 173, 10.1016/S0094-0143(21)00473-0 Raghavan, 1992, Hypercholesterolemia after chemotherapy for testis cancer, J Clin Oncol, 10, 1386, 10.1200/JCO.1992.10.9.1386 Richie, 1992, Neoplasms of the testis, 1222 Roth, 1988, Long-term complications of cisplatin-based chemotherapy for testis cancer, Semin Oncol, 15, 345 Roth, 1988, Cisplatin-based combination chemotherapy for disseminated germ cell tumors: Long-term follow-up, J Clin Oncol, 6, 1239, 10.1200/JCO.1988.6.8.1239 Skinner, 1982, Complications of thoracoabdominal retroperitoneal lymph node dissection, J Urol, 127, 1107, 10.1016/S0022-5347(17)54255-X Small, 1995, Management of specific malignancies: Testes, 1493 Stein, 1993, Testicular seminoma stage I: Treatment results and long-term follow-up (1968–1988), J Surg Oncol, 53, 175, 10.1002/jso.2930530309 Stephenson, 1995, Evaluation of reproductive capacity in germ cell tumor patients following treatment with cisplatin, etoposide, and bleomycin, J Clin Oncol, 13, 2278, 10.1200/JCO.1995.13.9.2278 Terebelo, 1983, Late relapse of testicular cancer, J Clin Oncol, 1, 566, 10.1200/JCO.1983.1.9.566 Vallis, 1995, Radiotherapy for stages I and II testicular seminoma: Results and morbidity in 238 patients, Br J Radiol, 68, 400, 10.1259/0007-1285-68-808-400 van Leeuwen, 1993, Second cancer risk following testicular cancer: A follow-up study of 1,909 patients, J Clin Oncol, 11, 415, 10.1200/JCO.1993.11.3.415 van Rooy, 1994, Long-term evaluation of postorchiectomy irradiation for stage I seminoma, Radiology, 191, 857, 10.1148/radiology.191.3.8184079 Vogelzang, 1981, Raynaud's phenomenon: A common toxicity after combination chemotherapy for testicular cancer, Ann Intern Med, 95, 288, 10.7326/0003-4819-95-3-288 Wanderas, 1997, Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients, Eur J Cancer, 33, 244, 10.1016/S0959-8049(96)00459-5 Wanderas, 1997, Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients, Eur J Cancer, 33, 253, 10.1016/S0959-8049(96)00458-3